Abstract
Genetic control of soluble transferrin receptor (sTfR) levels was demonstrated using family-based studies (GAIT, Genetic Analysis of Idiopathic Thrombophilia project); moreover, a genetic relationship was observed between sTfR and the risk for thrombosis, suggesting that these phenotypes shared genetic determinants. We studied the regions that control sTfR. To assess such regions, a full genome scan was carried out using 604 highly polymorphic deoxyribonucleic acid markers (resolution 7.3 cM) in 21 extended pedigrees (358 individuals). Then, a quantitative trait linkage analysis was performed using variance components methods. The genomewide scan linkage analysis showed two regions (quantitative trait locus or QTL) with significant limit of detection (LOD) scores (2q23.14, LOD score=2.64, nominal p=0.00024; 3q21.2, LOD score=1.94, nominal p=0.0014). There were no obvious candidate genes in these regions. In conclusion, this linkage analysis suggested the existence of a QTL in 2q23.14 that probably harbored a gene (or genes) controlling sTfR levels. Moreover, a second linkage signal was observed in 3q21.2; albeit the evidence for this second locus was lower. The next step will be to identify the gene(s) and its possible involvement in thrombosis and iron homeostasis.
Similar content being viewed by others
References
Blangero J, Williams JT, Almasy L (2003) Novel family-based approaches to genetic risk in thrombosis. J Thromb Haemost 1:1391–1397
Gambaro G, Anglani F, D’Angelo A (2000) Association studies of genetic polymorphisms and complex disease. Lancet 355:308–311
Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J (2000) Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 67:1452–1459
Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J (2003) Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 89:468–474
Almasy L, Soria JM, Souto JC, Coll I, Bacq D, Faure A, Mateo J, Borrell M, Muñoz X, Sala N, Stone WH, Lathrop M, Fontcuberta J, Blangero J (2003) A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q. Results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biol 23:508–511
Soria JM, Almasy L, Souto JC, Buil A, Martínez-Sánchez E, Mateo J, Borrell M, Stone WH, Lathrop M, Fontcuberta J, Blangero J (2003) A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood 101:163–167
Soria JM, Almasy L, Souto JC, Bacq D, Buil A, Faure A, Martínez-Marchán E, Mateo J, Borrell M, Stone W, Lathrop M, Fontcuberta J, Blangero J (2002) A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 70:567–574
Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lypoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606
Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101:1546–1551
Sullivan JL (1999) Iron and genetics of cardiovascular disease. Circulation 100:1260–1263
Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD (1999) Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100:1268–1273
Souto JC, Almasy L, Borrell M, Stone WH, Blaco-Vaca F, Soria JM, Blangero J, Fontcuberta J (2002) Thromboplastin–thrombomodulin-mediated time and serum folate levels are genetically correlated with risk of thromboembolic disease: results from the GAIT project. Thromb Haemost 87:68–73
Souto JC, Remacha A, Buil A, Almasy L, Blangero J, Fontcuberta J (2003) Genetic determinants of iron metabolism plasma phenotypes and their relationship with risk of thrombosis. Haematologica 88:1436–1438
Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211
Souto JC, Almasy L, Blangero J, Stone W, Borrell M, Urrutia T, Mateo J, Fontcuberta J (2001) Genetic regulation of plasma levels of vitamin-K dependent proteins involved in hemostasis. Thromb Haemost 85:88–92
Whitfield JB, Martin NG (1984) The effects of inheritance on constituents of plasma: a twin study on some biochemical variables. Ann Clin Biochem 21:176–183
Moyo VM, Mandishona E, Hasstedt SJ, Gangaidzo IT, Gomo ZAR, Khumalo H, Saungweme T, Kiire CF, Paterson AC, Bloom P, Mac Phail AP, Rouault T, Gordeuk VR (1998) Evidence of genetic transmission in African iron overload. Blood 91:1076–1082
Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C (2003) Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 102:1904–1910
Visapaa I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V, Payne GS, Makarow M, Van Coster R, Taylor RW, Turnbull DM, Suomalainen A, Peltonen L (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876
Esparza-Gordillo J, Soria JM, Buil A, Souto JC, Almasy L, Blangero J, Fontcuberta J, de Cordoba SR (2003) Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families. Immunogenetics 54:862–866
Acknowledgements
We are grateful to the Ministerio de Sanidad y Consumo (Spain) (grant FIS PI 20506), Fundació “la Caixa,” and Fundació d’Investigació Sant Pau for supporting this study. J. M. Soria and A. Buil were supported by FIS 99/3048 and FIS 01/A046, respectively. Statistical genetic analysis was supported by US National Institutes of Health grants MH59490 and HL70751.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Remacha, A.F., Souto, J.C., Soria, J.M. et al. Genomewide linkage analysis of soluble transferrin receptor plasma levels. Ann Hematol 85, 25–28 (2006). https://doi.org/10.1007/s00277-005-1092-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-005-1092-7